Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 19 Aug 2024 for Immix Biopharma, Inc., €17k.
Filing timeline
BuySaleCarey Ng
Insider track record
Disclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Carey Ng: trading record in brief
Carey Ng is a declared insider of Immix Biopharma, Inc., with filings sourced from SEC (Form 4). Between 20 December 2021 and 16 August 2024, the trades on record add up to 4 filings.
No open-market sale appears; the market trades are 3 purchases worth €152k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2024, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €24k. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The newest entry dates from 19 August 2024: an open-market purchase of €17k, in Immix Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Carey Ng
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
10,000 shares@ US$1.861.1% of flowCommon StockSEC:0001493152-24-033205:0
Canonical exit: 14 Nov 2024 (T+90)
10,000 shares@ US$2.5761.6% of flowCommon StockSEC:0001493152-23-032829:0
Canonical exit: 13 Dec 2023 (T+90)
1,000,221 shares@ US$0.8594.8% of flowCommon StockSEC:0001493152-21-032034:0
3 of 3 declarations
